References
- Anheim M, Tranchant C, Koenig M. The autosomal recessive cerebellar ataxias. N Engl J Med. 2012;366(7):636–646.
- Storey E. Genetic cerebellar ataxias. Semin Neurol. 2014;34:280–292.
- Paulson HL. The spinocerebellar ataxias. J Neuroophthalmol. 2009;29(3):227–237.
- Fogel BL. Autosomal-recessive cerebellar ataxias. Handb Clin Neurol. 2018;147:187–209.
- Burns R, Majczenko K, Xu J, et al. Homozygous splice mutation in CWF19L1 in a Turkish family with recessive ataxia syndrome. Neurology. 2014;83(23):2175–2182.
- Nguyen M, Boesten I, Hellebrekers DM, et al. Pathogenic CWF19L1 variants as a novel cause of autosomal recessive cerebellar ataxia and atrophy. Eur J Hum Genet. 2016;24(4):619–622.
- Evers C, Kaufmann L, Seitz A, et al. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy. Am J Med Genet A. 2016;170(6):1502–1509.
- Levy SE, Myers RM. Advancements in next-generation sequencing. Annu Rev Genomics Hum Genet. 2016;17:95–115.
- Marcián V, Filip P, Bareš M, et al. Cerebellar dysfunction and ataxia in patients with epilepsy: coincidence, consequence, or cause? Tremor Other Hyperkinet Mov (N Y). 2016;6:376.
- Yasam VR, Jakki SL, Senthil V, et al. A pharmacological overview of lamotrigine for the treatment of epilepsy. Expert Rev Clin Pharmacol. 2016;9(12):1533–1546.